Back to Pulmonology
Pulmonologyv2012Evidence-Based

DECAF Score for Acute Exacerbation of COPD

Predicts in-hospital mortality in acute COPD exacerbation using five clinical variables: Dyspnoea, Eosinopenia, Consolidation, Acidaemia, and atrial Fibrillation.

Clinical Input Parameters

years
Range: 35 — 120 years
Clinical Assessment
Awaiting Parameters
decaf assessment
—points
Ready to Calculate

Awaiting Clinical Input

Enter the clinical input parameters on the left and click Run Clinical Assessment to evaluate this medical calculator with deterministic clinical scoring.

Open in Web App
Clinical decision support tool for licensed medical practitioners. Confirm independently before prescribing or clinical action.

When & Why to Use

The DECAF Score for Acute Exacerbation of COPD is utilized in clinical practice for risk stratification, diagnostic probability estimation, and treatment decision-making within pulmonology.

Use this tool during initial patient intake, emergency department workup, or bedside assessment when objective clinical scoring is required to guide management or admission decisions.

Clinical Formula & Scoring Logic

DECAF Score = Dyspnoea (0-2 points) + Eosinopenia (0-1 point) + Consolidation (0-1 point) + Acidaemia (0-1 point) + atrial Fibrillation (0-1 point)

Clinical Pearls & Practice Notes

  • Score applies only to patients ≥35 years old with acute COPD exacerbation
  • Requires ≥10 pack-year smoking history for validity
  • Should only be used in hospitalized patients, not outpatient or stable COPD
  • Extended MRC Dyspnea Scale assesses functional limitation due to breathlessness
  • Eosinopenia defined as <0.05×10⁹/L (equivalent to <50 cells/μL)
  • Consolidation must be present on chest X-ray imaging
  • Acidemia requires arterial blood gas measurement with pH <7.30
  • Atrial fibrillation can be current or historical
  • Higher scores (3-6) warrant consideration of escalated care or palliative discussions
  • Score has been validated across multiple international populations
  • Superior prognostic accuracy compared to other COPD severity scores

Evidence & Literature Citations

  1. Steer J, Gibson J, Bourke SC. The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary disease. Thorax. 2012;67(11):970-976. doi: 10.1136/thoraxjnl-2012-202103.
  2. Echevarria C, Steer J, Heslop-Marshall K, et al. Validation of the DECAF score to predict hospital mortality in acute exacerbations of COPD. Thorax. 2016;71(2):133-140. doi: 10.1136/thoraxjnl-2015-207775.
  3. Zhou M, Chen Y, Yang M, et al. DECAF score as a mortality predictor for acute exacerbation of chronic obstructive pulmonary disease: a systematic review and meta-analysis. BMJ Open. 2021;11(2):e044923. doi: 10.1136/bmjopen-2020-044923.
  4. Nafae RM, Embarak S, Gad DM. Value of the DECAF score in predicting hospital mortality in patients with acute exacerbation of chronic obstructive pulmonary disease admitted to Zagazig University Hospitals, Egypt. Egypt J Chest Dis Tuberc. 2015;64(1):35-40. doi: 10.1016/j.ejcdt.2014.07.006.

Score Interpretation Ranges

Low Risk0 – 1 pts

Low mortality risk

Intermediate Risk2 – 2 pts

Intermediate mortality risk

High Risk3 – 6 pts

High mortality risk

Need Clinical Suite Access?

Run this calculator with patient history, laboratory integration, and drug interaction safety checks on the DexaMed clinician app.

Open in Web App

Clinical Decision Support (CDS) Notice & Legal Disclaimer

This medical calculator and its scoring interpretation are provided strictly for licensed healthcare professionals and medical trainees as an educational and clinical decision support instrument. It does not replace independent clinical judgment, comprehensive patient history, physical examination, or attending physician oversight. Not FDA-cleared as an autonomous diagnostic medical device. Read the full DexaMed Medical Disclaimer.